Moodley Y P, Dorasamy T, Venketasamy S, Naicker V, Lalloo U G
Respiratory Unit, Department of Medicine, University of Natal, Private Bag 7, Congella 4013, South Africa.
Thorax. 2000 Aug;55(8):696-9. doi: 10.1136/thorax.55.8.696.
An increased CD4:CD8 lymphocyte ratio and raised cytokine levels in bronchoalveolar lavage (BAL) fluid are characteristic of pulmonary sarcoidosis. Sputum induction has been used as a non-invasive tool for investigating the airways and may be useful in investigating inflammation in patients with sarcoidosis in whom endobronchial, peribronchial, and parenchymal inflammation is present. This study aimed to correlate the total and differential cell counts, CD4:CD8 ratio, and tumour necrosis factor (TNF)alpha levels between induced sputum and BAL fluid in patients with pulmonary sarcoidosis.
Fourteen patients with newly diagnosed biopsy proven sarcoidosis and six healthy controls were investigated. Sputum induction and BAL was carried out at the initial visit and repeated following six months of treatment with oral prednisone.
There was no correlation of differential cell counts between induced sputum and BAL fluid. The CD4:CD8 ratio in induced sputum correlated strongly with that in BAL fluid (5.5 (0. 4:1) versus 4.4 (0.2:1); r = 0.8, p<0.001) and the fall in the ratio following six months of treatment in sputum paralleled that in BAL fluid (3.4 (0.2:1) versus 2.4 (0.2:1)). The TNF alpha levels in sputum also correlated with levels in the BAL fluid (11.9 (1.5) pg/ml versus 17.6 (2.7) pg/ml; r = 0.8, p<0.001). The fall in sputum TNF alpha levels following six months of treatment paralleled the fall in BAL fluid levels (6.7 (0.9) pg/ml versus 11.6 (1.3) pg/ml).
The CD4:CD8 ratio and TNF alpha levels in induced sputum correlated with those in BAL fluid and paralleled changes with treatment. Induced sputum may therefore be a non-invasive surrogate for certain parameters in BAL fluid in patients with sarcoidosis.
支气管肺泡灌洗(BAL)液中CD4:CD8淋巴细胞比值升高和细胞因子水平升高是肺结节病的特征。痰液诱导已被用作一种研究气道的非侵入性工具,对于研究存在支气管内、支气管周围和实质炎症的结节病患者的炎症可能有用。本研究旨在比较肺结节病患者诱导痰与BAL液中的总细胞计数、分类细胞计数、CD4:CD8比值和肿瘤坏死因子(TNF)α水平。
对14例新诊断的经活检证实的结节病患者和6名健康对照者进行研究。在初次就诊时进行痰液诱导和BAL,并在口服泼尼松治疗6个月后重复进行。
诱导痰与BAL液中的分类细胞计数无相关性。诱导痰中的CD4:CD8比值与BAL液中的CD4:CD8比值密切相关(分别为5.5(0.4:1)和4.4(0.2:1);r = 0.8,p<0.001),且治疗6个月后痰中该比值的下降与BAL液中的下降情况平行(分别为3.4(0.2:1)和2.4(0.2:1))。痰中的TNFα水平也与BAL液中的水平相关(分别为11.9(1.5)pg/ml和17.6(2.7)pg/ml;r = 0.8,p<0.001)。治疗6个月后痰中TNFα水平的下降与BAL液中水平的下降情况平行(分别为6.7(0.9)pg/ml和11.6(1.3)pg/ml)。
诱导痰中的CD4:CD8比值和TNFα水平与BAL液中的相关,且与治疗后的变化情况平行。因此,诱导痰可能是结节病患者BAL液中某些参数的非侵入性替代指标。